#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangitis sclerosing Cutaneous lupus erythematosus Bronchopulmonary aspergillosis Heritable pulmonary arterial hypertension Ewing's sarcoma recurrent Gastrointestinal neuroendocrine tumour KBG syndrome Immunodeficiency Retinopathy proliferative Neonatal alloimmune thrombocytopenia Neurofibroma Restless legs syndrome Amyotrophic lateral sclerosis gene carrier Erythema multiforme Non-Hodgkin's lymphoma More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Treatment Urea cycle disorder – Treatment Haemolytic uraemic syndrome – Basic Information Myelodysplastic syndrome – Treatment Mantle cell lymphoma Cholangitis sclerosing – Diagnostics Atypical haemolytic uraemic syndrome Small intestine leiomyosarcoma – Treatment Glomerulonephritis membranous – Treatment Breast angiosarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Relatlimab Aztreonam Amphotericine B, Liposome Calcium Polystyrene Sulfonate Litifilimab 64CU-PSMA I&T Umeclidinium Atogepant [68GA]GA-NOTA-AE105 Meropenem Trihydrate Atorvastatin Calcium Auto4 Cat Epithelia Benzalkonium Chloride Rifapentine Sotrovimab Ondansetron Elexacaftor Ammonium Chloride Bp Clodronate Disodium More therapies…

    Learn about Your Condition

    Dermatitis Encephalitis Japanese B Cholestatic pruritus Joint stabilisation Vaginal cancer Bronchitis Graft versus host disease Testicular leiomyosarcoma Pleomorphic liposarcoma Anorexia nervosa Pathogen resistance Aplasia pure red cell Oesophageal carcinoma Genital herpes Metastases to meninges More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

IgA nephropathy

  • Study of felzartamab compared to placebo in adults with IgA nephropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Cetirizine Dihydrochloride
    • Codeine Phosphate
    Belgium Bulgaria Croatia Czechia France Germany +5

  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6

  • Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    • Nephrotic syndrome
    • IgA nephropathy
    Investigated Drugs:
    • Atacicept
    Belgium France Germany Italy Poland Spain

  • Study on Ravulizumab for Children with IgA Nephropathy (Ages 2-17)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Ravulizumab
    Italy Spain

  • Study on the Effectiveness and Safety of Budesonide and Prednisone for Children with Primary IgA Nephropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Budesonide
    • Prednisone
    Poland

  • Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

    Recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Atrasentan Hydrochloride
    • ZIGAKIBART
    France Germany Italy Poland Portugal Spain
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!